| RS138416665 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1384167696 |
SLC12A3
|
Health Risk |
Likely pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS138417551 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Cohen syndrome |
| RS1384182085 |
ARHGEF9
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 8 |
| RS138418494 |
MUSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 9, Fetal akinesia deformation sequence 1 |
| RS138419017 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS138419275 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 14, Cardiovascular phenotype |
| RS138419523 |
GRIA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138419634 |
TTI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome, Inborn genetic diseases |
| RS138420081 |
GORAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1384212298 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS138421793 |
MC2R
|
Health Risk |
Conflicting classifications of pathogenicity |
Glucocorticoid deficiency 1, Glucocorticoid deficiency 1 |
| RS138421862 |
UNC80
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1384228127 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS138423094 |
RFXANK
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, MHC class II deficiency |
| RS138423103 |
DGAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138423108 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness autosomal dominant 2, Retinitis pigmentosa |
| RS138423670 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS1384237868 |
FMO3
|
Health Risk |
Pathogenic/Likely pathogenic |
Trimethylaminuria, Trimethylaminuria |
| RS138423878 |
CFAP43
|
Health Risk |
Pathogenic |
— |
| RS1384239050 |
MMP21
|
Health Risk |
Pathogenic |
— |
| RS138424013 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS138424288 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Inborn genetic diseases |
| RS138426138 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS138427178 |
PDE11A
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmented nodular adrenocortical disease, primary |
| RS138427376 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Inborn genetic diseases |
| RS138427861 |
DYM
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138428438 |
LRBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to LRBA deficiency, Inborn genetic diseases |
| RS138428805 |
CENPF
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138429045 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Congenital contractural arachnodactyly |
| RS138429238 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Inborn genetic diseases |
| RS1384292566 |
COL9A3
|
Health Risk |
Likely pathogenic |
Lattice retinal degeneration, Retinal detachment |
| RS1384293775 |
LAMB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pierson syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS1384295949 |
KBTBD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Nemaline myopathy 6 |
| RS1384297085 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS1384298522 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1384309620 |
XPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum group A, Xeroderma pigmentosum group A |
| RS1384312757 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1384315216 |
PHYH
|
Health Risk |
Pathogenic |
— |
| RS1384322636 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1384323646 |
SYNE1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS138432416 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, HYPERHOMOCYSTEINEMIA |
| RS138433243 |
HUWE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS138434001 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS1384342700 |
HPS6
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1384344292 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS138435128 |
SDR9C7
|
Health Risk |
Conflicting classifications of pathogenicity |
Ichthyosis, congenital |
| RS138435568 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS138435584 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
DDX41-related hematologic malignancy predisposition syndrome, Inborn genetic diseases |
| RS138435590 |
ADAMTS18
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Inborn genetic diseases |
| RS1384360004 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Familial hypobetalipoproteinemia 1 |
| RS1384363306 |
CDH3
|
Health Risk |
Pathogenic |
— |
| RS138436961 |
MCEE
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency, Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency |
| RS138437422 |
LARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1384374956 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS138437526 |
SPTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 3, Elliptocytosis 3 |
| RS138437710 |
KRT74
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138437852 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 22, Autosomal recessive nonsyndromic hearing loss 37 |
| RS138437966 |
AP4M1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 50, AP4M1-related disorder |
| RS138438183 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1384386872 |
ETFA
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS138438849 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1384393001 |
ATP6V0A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive distal renal tubular acidosis, Renal tubular acidosis |
| RS138439950 |
TK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3 |
| RS1384402545 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1384411524 |
TBX18
|
Health Risk |
Pathogenic |
Congenital anomalies of kidney and urinary tract 2, Congenital anomalies of kidney and urinary tract 2 |
| RS138441172 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, DNAH5-related disorder |
| RS1384412486 |
KLHL40
|
Health Risk |
Pathogenic |
Nemaline myopathy 8, Nemaline myopathy 8 |
| RS138441444 |
COPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune interstitial lung disease-arthritis syndrome, Autoimmune interstitial lung disease-arthritis syndrome |
| RS138441779 |
TANGO2
|
Health Risk |
Conflicting classifications of pathogenicity |
TANGO2-related disorder, Inborn genetic diseases |
| RS138442198 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pulmonary alveolar proteinosis, Hereditary pulmonary alveolar proteinosis |
| RS138443282 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS138443479 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Autoinflammatory syndrome |
| RS138443787 |
CCDC50
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 44, Hearing impairment |
| RS138444697 |
CYP4V2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bietti crystalline corneoretinal dystrophy, Retinal dystrophy |
| RS138445233 |
CNNM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Jalili syndrome, Jalili syndrome |
| RS138445573 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1384460756 |
ITGA7
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS1384466058 |
LRAT
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 14, Leber congenital amaurosis 14 |
| RS138447102 |
DEAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-epilepsy-extrapyramidal syndrome, DEAF1-related disorder |
| RS138447206 |
ZAP70
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to ZAP70 deficiency, ZAP70-related disorder |
| RS1384474600 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS138447882 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS1384480619 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation 1 |
| RS138448968 |
TPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 2, Autosomal recessive spinocerebellar ataxia 7 |
| RS138449068 |
COQ7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138449255 |
SLC26A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypersulfaturia, Nephrolithiasis susceptibility caused by SLC26A1 |
| RS138449445 |
SDCCAG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS1384495572 |
ATP7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, X-linked distal spinal muscular atrophy type 3 |
| RS1384496494 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Corpus callosum |
| RS138449967 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
3-Methylglutaconic aciduria type 3, Optic atrophy 3 |
| RS138450235 |
MPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS138450474 |
SCN1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Brugada syndrome 5, Brugada syndrome 5 |
| RS138450923 |
GPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, Inborn genetic diseases |
| RS1384515505 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1384516142 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1384523881 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS138452752 |
SLC25A19
|
Health Risk |
Conflicting classifications of pathogenicity |
SLC25A19-related disorder, SLC25A19-related disorder |
| RS138452760 |
PRICKLE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, progressive myoclonic |
| RS138452803 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1AA |